OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
3
Results
Show all
Save search
Copy query
Show results for
Proteomics
(3)
Organisms
Homo sapiens
(2)
Andropogon gerardi
(1)
Bacteria
(1)
Canis lupus familiaris
(1)
Clavibacter nebraskensis NCPPB 2581
(1)
Cnidaria
(1)
Ensifer adhaerens
(1)
Fasciola
(1)
Human alphaherpesvirus 1 strain 17
(1)
Human alphaherpesvirus 1 strain KOS
(1)
Human betaherpesvirus 5
(1)
Human herpesvirus 2 strain 186
(1)
Mesocricetus auratus
(1)
Miscanthus x giganteus
(1)
Mus musculus
(1)
Panicum virgatum
(1)
Platyhelminthes
(1)
Pseudomonas aeruginosa PA103
(1)
Rattus norvegicus
(1)
Rattus rattus
(1)
Rhodococcus jostii RHA1
(1)
Rhodopseudomonas palustris
(1)
Shigella
(1)
Sorghastrum nutans
(1)
Spirochaeta sp. ELBA
(1)
Streptococcus dysgalactiae subsp. equisimilis SK1249
(1)
Streptococcus pneumoniae
(1)
Streptomyces coelicolor A3(2)
(1)
Tripsacum dactyloides
(1)
Trypanosoma vivax Y486
(1)
Repository
jPOST
(2)
pride
(1)
Technology Type
Affinity purification coupled with mass spectrometry proteomics
(1)
Mass Spectrometry
(1)
Publication Date
2024
(2)
2022
(1)
Lab affiliation
Department of Physiology,Juntendo University Graduate School of Medicine
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Identification of UFM-1 binding proteins LC-MS/MS
UFM-1 binding proteins were identified by mass spectroscopic analysis
ORGANISM(S):
Homo sapiens (Human)
2022-11-29
|
PXD038409
|
Pride
Ufbp1
Cyb5r3
Ufl1
Ufm-1
Lc-ms/ms
Cite
Proteome data on human MDS-L cells
Shotgun mass spectrometric analysis of WT and TOPORS KO MDS-L cells
ORGANISM(S):
Homo Sapiens (human)
2024-03-08
|
PXD048275
|
JPOST Repository
Cite
MS data on ubiquitinated proteins
Mass spectrometric analysis of ubiquitinated proteins in MDS-L cells
ORGANISM(S):
Homo Sapiens (human)
2024-03-08
|
PXD044347
|
JPOST Repository
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets
